HopeStage
Back to overview

Anxiety studies

Topics
More filters

Anxiety

Anxiety conditions involve intense, persistent fears or worries that can interfere with everyday life.

5111studies shown
Showing 877-888 of 5,111
Drug study icon
Not recruitingEUCTR 2006-006339-31

AN 8 WEEK, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 3 TRIAL OF PREGABALIN (150 600 MG/DAY) IN THE ADJUNCTIVE TREATMENT OF PATIENTS WITH GENERALIZED ANXIETY DISORDER (GAD) WHO HAVE NOT OPTIMALLY RESP...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
AnxietyHistorical research record
Countries
Czechia, Estonia, Finland, + 1 other
Sponsor
Pfizer Inc., 235 East 42nd Street, New York, NY 10017, United states [...] 1. Pfizer Inc., 235 East 42nd Street, New York, NY 10017, United states 2. Pfizer Oy
Behavioral study icon
CompletedACTRN12617000060347

A study that test the effects of a mobile phone application that delivers a psychological health intervention to reduce social anxiety symptoms.

Official study title

Randomised Controlled Trail testing the effectiveness of an Ecological Momentary Intervention (EMI) in adults with social anxiety symptoms

This study has finished and is no longer accepting participants.

In Australia
Anxiety, DepressionInterventional studyAges 18+
Countries
Australia
Sponsor
Australian National University
Behavioral study icon
CompletedACTRN12605000392662

Comparative Study on Group Therapy for Generalised Anxiety Disorder

Official study title

A randomised study to compare the effectiveness of three forms of group therapy for the treatment of generalised anxiety disorder. Outcomes measured are changes in symptoms and psychological processes commonly associated with GAD.

This study has finished and is no longer accepting participants.

In Australia
AnxietyInterventional studyAges 18–65
Countries
Australia
Sponsor
Esben Strodl
Device study icon
CompletedACTRN12623000250639

High-definition transcranial grey noise stimulation (HD-tGNS) as an intervention for generalised anxiety disorder (GAD): A proof of concept study

Official study title

High-definition transcranial grey noise stimulation (HD-tGNS) for the treatment of generalised anxiety disorder (GAD) in adults: A proof of concept study

This study has finished and is no longer accepting participants.

In New Zealand
AnxietyInterventional studyAges 18–60
Countries
New Zealand
Sponsor
Otago University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.